Jonathan L. Coloff, Ph.D.
Affiliations: | 2010 | Pharmacology | Duke University, Durham, NC |
| 2018- | College of Medicine | University of Illinois at Chicago, Chicago, IL, United States |
Area:
Pharmacology, Molecular Biology, OncologyWebsite:
https://cancer.uillinois.edu/member/jonathan-coloff-phd/Google:
"Jonathan Coloff"Parents
Sign in to add mentor| Jeffrey C. Rathmell | grad student | 2010 | Duke | |
| (Akt, glucose metabolism, and the Bcl-2 family.) | ||||
Children
Sign in to add trainee| Philippa Aurelie Burns | grad student | ||
| Lina Lietuvninkas | grad student | ||
| Mete Emir Ozgurses | grad student | 2020-2026 | UIC College of Medicine |
| vipin singh rawat | post-doc | UIC College of Medicine |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jonker PB, Sadullozoda M, Cognet G, et al. (2025) Microenvironmental arginine restriction sensitizes pancreatic cancers to polyunsaturated fatty acids by suppression of lipid synthesis. Biorxiv : the Preprint Server For Biology |
| Hecht F, Zocchi M, Tuttle ET, et al. (2024) Catabolism of extracellular glutathione supplies amino acids to support tumor growth. Biorxiv : the Preprint Server For Biology |
| Conger KO, Chidley C, Ozgurses ME, et al. (2024) ASCT2 is a major contributor to serine uptake in cancer cells. Cell Reports. 43: 114552 |
| Rawat V, DeLear P, Prashanth P, et al. (2024) Drug screening in human physiologic medium identifies uric acid as an inhibitor of rigosertib efficacy. Jci Insight |
| Conger KO, Chidley C, Ozgurses ME, et al. (2023) ASCT2 is the primary serine transporter in cancer cells. Biorxiv : the Preprint Server For Biology |
| Rawat V, DeLear P, Prashanth P, et al. (2023) Drug screening in human physiologic medium identifies uric acid as an inhibitor of rigosertib efficacy. Biorxiv : the Preprint Server For Biology |
| de Wet L, Williams A, Gillard M, et al. (2022) Correction to: SOX2 mediates metabolic reprogramming of prostate cancer cells. Oncogene. 41: 1234 |
| de Wet L, Williams A, Gillard M, et al. (2022) SOX2 mediates metabolic reprogramming of prostate cancer cells. Oncogene |
| Choi BH, Rawat V, Högström J, et al. (2022) Lineage-specific silencing of PSAT1 induces serine auxotrophy and sensitivity to dietary serine starvation in luminal breast tumors. Cell Reports. 38: 110278 |
| Keibler MA, Dong W, Korthauer KD, et al. (2021) Differential Substrate Use in EGF- and Oncogenic KRAS-Stimulated Human Mammary Epithelial Cells. The Febs Journal |